The Latest Cardiac and Vascular News
POWER PAD II IDE trial evaluates safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it will present 30-day results of its […]
PALM SPRINGS, Calif., Sept. 10, 2025 /PRNewswire/ — The VIVA Foundation will once again showcase the most influential new data in vascular medicine on a global stage. From Saturday, November 1, through Tuesday, November 4, results from 23 clinical trials will be presented during The…
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., the innovator of shape memory polymer for endovascular applications, announced the completion of patient enrollment in the EMBO Post Market Surveillance (EMBO-PMS) Registry, the Company’s prospective, multicenter registry of the IMPEDE and IMPEDE-FX Embolization Plugs, and IMPEDE-FX RapidFill Device when used for peripheral […]
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System.
During PAD Awareness Month, the Society for Vascular Surgery Urges Americans to Learn How to Safeguard Their Vascular Health ROSEMONT, Ill., Sept. 8, 2025 /PRNewswire/ — Despite vascular disease dominating headlines in recent months—from prominent public figures with visible symptoms and…
Next-generation deliverability and control for peripheral embolization — available September 8, 2025 IRVINE, Calif., Sept. 8, 2025 /PRNewswire/ — ASAHI INTECC today announced the U.S. commercial launch of Veloute™ and Tellus™. These medical devices are indicated for angiography and…
MINNEAPOLIS, Sept. 4, 2025 /PRNewswire/ — VentureMed Group, Inc., a privately held leader in medical device innovations for arteriovenous (AV) access and peripheral arterial disease (PAD), was recently featured in a published study on the outcomes of FLEX VP + DCB in the Journal of…
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony® Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition caused by blood clots blocking an artery in the lungs. This clearance expands the use of Symphony – previously for the treatment of […]
MINNEAPOLIS, Aug. 29, 2025 /PRNewswire/ — Phraxis, Inc., a leader in vascular access innovation, today announced the successful completion of the first commercial case using the EndoForce™ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide….
Venova Medical Receives FDA IDE Approval for the VENOS-3 Study LOS GATOS, Calif., Aug. 21, 2025 /PRNewswire-PRWeb/ — Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, today announced approval from the US Food and Drug Administration (FDA) to […]
